GSK to support some African countries

GSK has launched the first call for proposals for its Africa NCD Open Lab, with a commitment of £25m funding over five years to support much-needed scientific research into non-communicable diseases (NCDs) such as cancer and diabetes.

The Africa NCD Open Lab was established by GSK earlier this year, as part of a series of strategic investments in sub-Saharan Africa. In this region, and across developing countries, non-communicable diseases are becoming more prevalent, and we need to learn more about how – and why – these diseases manifest differently in this setting.

Up to £4m will be available in this first funding round, to support successful proposals from researchers in Côte d’Ivoire, Cameroon, Ghana, The Gambia, Nigeria, Kenya, Uganda and Malawi.

The Africa NCD Open Lab aims to address this through the creation of an innovative research network that will see GSK scientists collaborate with researchers across...